Urodilatin (INN: Ularitide) Ein neues Peptid in der Intensivbehandlung des akuten Nierenversagens nach Lebertransplantation View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1996-04

AUTHORS

E.-R. Kuse, M. Meyer, R. Constantin, K. Oldhafer, H.-J. Schlitt, P. Schulz-Knappe, H. J. Überbacher, R. Pichlmayr, W.-G. Forssmann

ABSTRACT

Acute renal failure (ARF) is a serious complication following liver transplantation. Many therapeutic regimens have been used so far but with limited success. Urodilatin (URO) is a new member of the atrial natriuretic peptide (ANP) family. When administered intravenously, URO induces strong diuresis and natriuresis with tolerable hemodynamic side effects. Preliminary non-controlled clinical studies demonstrate beneficial effects using URO as a therapeutic agent in patients suffering from ARF following heart and liver transplantation (HTx, LTx). These results prompted us to initiate this first controlled clinical trial to investigate whether URO infusion can improve renal function in patients with emerging ARF following LTx.Method. We initiated a randomized, double-blind, placebo-controlled study comparing five patients receiving i.v. URO infusion (20 ng/kg bw/min) with four placebo patients after informed consent was obtained. Optional inclusion criteria were oliguria/anuria (<0.5 ml/kg/h), refractory to conventional treatment including administration of furosemide and dopamine, increase of serum creatinine to a least 200% of preoperative values, and BUN levels ≥25 mmol/l. The primary parameters for efficacy was the frequency of hemodialysis/hemofiltration.Results. The frequency of hemodialysis/hemofiltration during URO or placebo infusion was significantly reduced (P=0.03) in the URO-treated patients in comparison with placebo. BUN levels did not differ between two groups, but serum creatinine levels were consistently lower in the URO group. Diuresis tended to be stronger in the URO group, maintaining high levels despite a significant reduction in the administration of furosemide in comparison with placebo.Conclusion. We conclude that URO seems to be a new approach for the treatment of therapy-resistant postoperative ARF following LTx. More... »

PAGES

351-358

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s001010050271

DOI

http://dx.doi.org/10.1007/s001010050271

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1054510475

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8702053


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Kidney Injury", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrial Natriuretic Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diuresis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diuretics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Function Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptide Fragments", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Postoperative Complications", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Renal Dialysis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Klinik f\u00fcr Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuse", 
        "givenName": "E.-R.", 
        "id": "sg:person.0664301646.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664301646.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nieders\u00e4chsisches Institut f\u00fcr Peptid-Forschung (IPF), Hannover, XX", 
          "id": "http://www.grid.ac/institutes/grid.420011.6", 
          "name": [
            "Nieders\u00e4chsisches Institut f\u00fcr Peptid-Forschung (IPF), Hannover, XX"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meyer", 
        "givenName": "M.", 
        "id": "sg:person.01003113502.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003113502.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Klinik f\u00fcr Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Constantin", 
        "givenName": "R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Klinik f\u00fcr Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oldhafer", 
        "givenName": "K.", 
        "id": "sg:person.014700460114.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014700460114.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Klinik f\u00fcr Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schlitt", 
        "givenName": "H.-J.", 
        "id": "sg:person.010361144542.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010361144542.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nieders\u00e4chsisches Institut f\u00fcr Peptid-Forschung (IPF), Hannover, XX", 
          "id": "http://www.grid.ac/institutes/grid.420011.6", 
          "name": [
            "Nieders\u00e4chsisches Institut f\u00fcr Peptid-Forschung (IPF), Hannover, XX"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schulz-Knappe", 
        "givenName": "P.", 
        "id": "sg:person.01243260701.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243260701.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Boehringer Mannheim GmbH, Mannheim, XX", 
          "id": "http://www.grid.ac/institutes/grid.424277.0", 
          "name": [
            "Boehringer Mannheim GmbH, Mannheim, XX"
          ], 
          "type": "Organization"
        }, 
        "familyName": "\u00dcberbacher", 
        "givenName": "H. J.", 
        "id": "sg:person.01071356132.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071356132.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Klinik f\u00fcr Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Klinik f\u00fcr Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pichlmayr", 
        "givenName": "R.", 
        "id": "sg:person.0767110303.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767110303.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nieders\u00e4chsisches Institut f\u00fcr Peptid-Forschung (IPF), Hannover, XX", 
          "id": "http://www.grid.ac/institutes/grid.420011.6", 
          "name": [
            "Nieders\u00e4chsisches Institut f\u00fcr Peptid-Forschung (IPF), Hannover, XX"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Forssmann", 
        "givenName": "W.-G.", 
        "id": "sg:person.01316354712.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316354712.56"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1996-04", 
    "datePublishedReg": "1996-04-01", 
    "description": "Acute renal failure (ARF) is a serious complication following liver transplantation. Many therapeutic regimens have been used so far but with limited success. Urodilatin (URO) is a new member of the atrial natriuretic peptide (ANP) family. When administered intravenously, URO induces strong diuresis and natriuresis with tolerable hemodynamic side effects. Preliminary non-controlled clinical studies demonstrate beneficial effects using URO as a therapeutic agent in patients suffering from ARF following heart and liver transplantation (HTx, LTx). These results prompted us to initiate this first controlled clinical trial to investigate whether URO infusion can improve renal function in patients with emerging ARF following LTx.Method. We initiated a randomized, double-blind, placebo-controlled study comparing five patients receiving i.v. URO infusion (20\u2005ng/kg bw/min) with four placebo patients after informed consent was obtained. Optional inclusion criteria were oliguria/anuria (<0.5\u2005ml/kg/h), refractory to conventional treatment including administration of furosemide and dopamine, increase of serum creatinine to a least 200% of preoperative values, and BUN levels \u226525\u2005mmol/l. The primary parameters for efficacy was the frequency of hemodialysis/hemofiltration.Results. The frequency of hemodialysis/hemofiltration during URO or placebo infusion was significantly reduced (P=0.03) in the URO-treated patients in comparison with placebo. BUN levels did not differ between two groups, but serum creatinine levels were consistently lower in the URO group. Diuresis tended to be stronger in the URO group, maintaining high levels despite a significant reduction in the administration of furosemide in comparison with placebo.Conclusion. We conclude that URO seems to be a new approach for the treatment of therapy-resistant postoperative ARF following LTx.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s001010050271", 
    "inLanguage": "de", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017033", 
        "issn": [
          "0003-2417", 
          "1432-055X"
        ], 
        "name": "Der Anaesthesist", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "45"
      }
    ], 
    "keywords": [
      "acute renal failure", 
      "hemodialysis/hemofiltration", 
      "administration of furosemide", 
      "URO infusion", 
      "URO group", 
      "liver transplantation", 
      "BUN levels", 
      "non-controlled clinical study", 
      "placebo-controlled study", 
      "postoperative acute renal failure", 
      "atrial natriuretic peptide family", 
      "hemodynamic side effects", 
      "serum creatinine levels", 
      "natriuretic peptide family", 
      "placebo patients", 
      "placebo infusion", 
      "renal function", 
      "serum creatinine", 
      "renal failure", 
      "preoperative values", 
      "creatinine levels", 
      "serious complications", 
      "therapeutic regimens", 
      "strong diuresis", 
      "clinical trials", 
      "inclusion criteria", 
      "clinical studies", 
      "urodilatin", 
      "side effects", 
      "patients", 
      "conventional treatment", 
      "beneficial effects", 
      "therapeutic agents", 
      "infusion", 
      "informed consent", 
      "placebo", 
      "LTx", 
      "diuresis", 
      "transplantation", 
      "significant reduction", 
      "hemofiltration", 
      "peptide family", 
      "furosemide", 
      "administration", 
      "treatment", 
      "group", 
      "natriuresis", 
      "anuria", 
      "high levels", 
      "regimens", 
      "complications", 
      "creatinine", 
      "levels", 
      "limited success", 
      "trials", 
      "dopamine", 
      "efficacy", 
      "peptid", 
      "heart", 
      "study", 
      "consent", 
      "effect", 
      "failure", 
      "agents", 
      "frequency", 
      "criteria", 
      "increase", 
      "reduction", 
      "comparison", 
      "new member", 
      "family", 
      "function", 
      "primary parameters", 
      "members", 
      "success", 
      "results", 
      "values", 
      "new approach", 
      "de", 
      "approach", 
      "parameters", 
      "tolerable hemodynamic side effects", 
      "Preliminary non-controlled clinical studies", 
      "Optional inclusion criteria", 
      "therapy-resistant postoperative ARF", 
      "Urodilatin (INN: Ularitide) Ein neues Peptid", 
      "Ein neues Peptid", 
      "neues Peptid", 
      "der Intensivbehandlung des", 
      "Intensivbehandlung des", 
      "Nierenversagens", 
      "Lebertransplantation"
    ], 
    "name": "Urodilatin (INN: Ularitide) Ein neues Peptid in der Intensivbehandlung des akuten Nierenversagens nach Lebertransplantation", 
    "pagination": "351-358", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1054510475"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s001010050271"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8702053"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s001010050271", 
      "https://app.dimensions.ai/details/publication/pub.1054510475"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_286.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s001010050271"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s001010050271'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s001010050271'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s001010050271'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s001010050271'


 

This table displays all metadata directly associated to this object as RDF triples.

283 TRIPLES      21 PREDICATES      135 URIs      126 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s001010050271 schema:about N12b8e9311bb84c609ba4151c854dd7fc
2 N2991453967a14d96b1dc80f9250be3a3
3 N417d70d465b545d0aef48bd1e9794864
4 N4f66af68f86d498a8e91d0e453288c6a
5 N6d410c0abdca4ef78c642dad8045c3a9
6 N7b45e0ae5da74f1cb4b59556dee7daa8
7 N960e7ba76db943efb93dcc346b43b435
8 N98b9234a32a5490a93b3b4c7e3e99654
9 N9b471ef5c75f486b9cfde8ea8db48933
10 Nc8feb28fd8a84d96a6c4721056cb5b7c
11 Ndc0ce624c6da48e0a0a8a7dd74149203
12 Ne7d8a2c6f350413c838a054f5888c518
13 Neb9783781abd4491b8a9d0e2ed0f6064
14 Nf3408a8bb9054419b105390e596fbd56
15 Nf5fc5c69becb406189e6deb65a003b18
16 Nfa34a605b2f346b087419c48c666dec6
17 anzsrc-for:11
18 anzsrc-for:1102
19 anzsrc-for:1103
20 schema:author N71b2d70b484f4033b240dc676c21e4a9
21 schema:datePublished 1996-04
22 schema:datePublishedReg 1996-04-01
23 schema:description Acute renal failure (ARF) is a serious complication following liver transplantation. Many therapeutic regimens have been used so far but with limited success. Urodilatin (URO) is a new member of the atrial natriuretic peptide (ANP) family. When administered intravenously, URO induces strong diuresis and natriuresis with tolerable hemodynamic side effects. Preliminary non-controlled clinical studies demonstrate beneficial effects using URO as a therapeutic agent in patients suffering from ARF following heart and liver transplantation (HTx, LTx). These results prompted us to initiate this first controlled clinical trial to investigate whether URO infusion can improve renal function in patients with emerging ARF following LTx.Method. We initiated a randomized, double-blind, placebo-controlled study comparing five patients receiving i.v. URO infusion (20 ng/kg bw/min) with four placebo patients after informed consent was obtained. Optional inclusion criteria were oliguria/anuria (<0.5 ml/kg/h), refractory to conventional treatment including administration of furosemide and dopamine, increase of serum creatinine to a least 200% of preoperative values, and BUN levels ≥25 mmol/l. The primary parameters for efficacy was the frequency of hemodialysis/hemofiltration.Results. The frequency of hemodialysis/hemofiltration during URO or placebo infusion was significantly reduced (P=0.03) in the URO-treated patients in comparison with placebo. BUN levels did not differ between two groups, but serum creatinine levels were consistently lower in the URO group. Diuresis tended to be stronger in the URO group, maintaining high levels despite a significant reduction in the administration of furosemide in comparison with placebo.Conclusion. We conclude that URO seems to be a new approach for the treatment of therapy-resistant postoperative ARF following LTx.
24 schema:genre article
25 schema:inLanguage de
26 schema:isAccessibleForFree false
27 schema:isPartOf N299869093eb548bd808b8985ff90f529
28 Ne8472b6b4343442b829786379fb7f807
29 sg:journal.1017033
30 schema:keywords BUN levels
31 Ein neues Peptid
32 Intensivbehandlung des
33 LTx
34 Lebertransplantation
35 Nierenversagens
36 Optional inclusion criteria
37 Preliminary non-controlled clinical studies
38 URO group
39 URO infusion
40 Urodilatin (INN: Ularitide) Ein neues Peptid
41 acute renal failure
42 administration
43 administration of furosemide
44 agents
45 anuria
46 approach
47 atrial natriuretic peptide family
48 beneficial effects
49 clinical studies
50 clinical trials
51 comparison
52 complications
53 consent
54 conventional treatment
55 creatinine
56 creatinine levels
57 criteria
58 de
59 der Intensivbehandlung des
60 diuresis
61 dopamine
62 effect
63 efficacy
64 failure
65 family
66 frequency
67 function
68 furosemide
69 group
70 heart
71 hemodialysis/hemofiltration
72 hemodynamic side effects
73 hemofiltration
74 high levels
75 inclusion criteria
76 increase
77 informed consent
78 infusion
79 levels
80 limited success
81 liver transplantation
82 members
83 natriuresis
84 natriuretic peptide family
85 neues Peptid
86 new approach
87 new member
88 non-controlled clinical study
89 parameters
90 patients
91 peptid
92 peptide family
93 placebo
94 placebo infusion
95 placebo patients
96 placebo-controlled study
97 postoperative acute renal failure
98 preoperative values
99 primary parameters
100 reduction
101 regimens
102 renal failure
103 renal function
104 results
105 serious complications
106 serum creatinine
107 serum creatinine levels
108 side effects
109 significant reduction
110 strong diuresis
111 study
112 success
113 therapeutic agents
114 therapeutic regimens
115 therapy-resistant postoperative ARF
116 tolerable hemodynamic side effects
117 transplantation
118 treatment
119 trials
120 urodilatin
121 values
122 schema:name Urodilatin (INN: Ularitide) Ein neues Peptid in der Intensivbehandlung des akuten Nierenversagens nach Lebertransplantation
123 schema:pagination 351-358
124 schema:productId N370afce9c98c40e488b1ce9fae95bb12
125 N3fc748130e784ff2ba400e9c849410cb
126 Nfb9f66d2435f4368b8bce9c17efbda61
127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054510475
128 https://doi.org/10.1007/s001010050271
129 schema:sdDatePublished 2022-01-01T18:08
130 schema:sdLicense https://scigraph.springernature.com/explorer/license/
131 schema:sdPublisher Nd86ce6fb2a5f402eac48f1edef75c9b4
132 schema:url https://doi.org/10.1007/s001010050271
133 sgo:license sg:explorer/license/
134 sgo:sdDataset articles
135 rdf:type schema:ScholarlyArticle
136 N12b8e9311bb84c609ba4151c854dd7fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Aged
138 rdf:type schema:DefinedTerm
139 N197578b3d72c43a7a04a763b6e986ac2 rdf:first sg:person.01003113502.88
140 rdf:rest N82959a57d2da4e8696f2e8d1a4d52887
141 N2991453967a14d96b1dc80f9250be3a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Renal Dialysis
143 rdf:type schema:DefinedTerm
144 N299869093eb548bd808b8985ff90f529 schema:issueNumber 4
145 rdf:type schema:PublicationIssue
146 N370afce9c98c40e488b1ce9fae95bb12 schema:name dimensions_id
147 schema:value pub.1054510475
148 rdf:type schema:PropertyValue
149 N3fc748130e784ff2ba400e9c849410cb schema:name pubmed_id
150 schema:value 8702053
151 rdf:type schema:PropertyValue
152 N417d70d465b545d0aef48bd1e9794864 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Peptide Fragments
154 rdf:type schema:DefinedTerm
155 N4f66af68f86d498a8e91d0e453288c6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Postoperative Complications
157 rdf:type schema:DefinedTerm
158 N5bb7f08e72da44b092b6d772baa41d44 rdf:first sg:person.01243260701.18
159 rdf:rest Nc34f74123ac54b11aeec93d5848e40c7
160 N67857bfd19444507955b1e3958f97d2b rdf:first sg:person.01316354712.56
161 rdf:rest rdf:nil
162 N6d410c0abdca4ef78c642dad8045c3a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Middle Aged
164 rdf:type schema:DefinedTerm
165 N6e90ff6ad10445f4be2439b434583a1e rdf:first sg:person.014700460114.77
166 rdf:rest Nf96b73bdba9942f6942d81126a42d171
167 N71b2d70b484f4033b240dc676c21e4a9 rdf:first sg:person.0664301646.04
168 rdf:rest N197578b3d72c43a7a04a763b6e986ac2
169 N7b45e0ae5da74f1cb4b59556dee7daa8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Acute Kidney Injury
171 rdf:type schema:DefinedTerm
172 N82959a57d2da4e8696f2e8d1a4d52887 rdf:first Nb11643a373d44c3481bcebd46dbad8a2
173 rdf:rest N6e90ff6ad10445f4be2439b434583a1e
174 N960e7ba76db943efb93dcc346b43b435 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Male
176 rdf:type schema:DefinedTerm
177 N98b9234a32a5490a93b3b4c7e3e99654 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Humans
179 rdf:type schema:DefinedTerm
180 N9b471ef5c75f486b9cfde8ea8db48933 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Atrial Natriuretic Factor
182 rdf:type schema:DefinedTerm
183 Nb11643a373d44c3481bcebd46dbad8a2 schema:affiliation grid-institutes:None
184 schema:familyName Constantin
185 schema:givenName R.
186 rdf:type schema:Person
187 Nc34f74123ac54b11aeec93d5848e40c7 rdf:first sg:person.01071356132.07
188 rdf:rest Nf37bf29e7fd6489db61fedd67564d4cf
189 Nc8feb28fd8a84d96a6c4721056cb5b7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Liver Transplantation
191 rdf:type schema:DefinedTerm
192 Nd86ce6fb2a5f402eac48f1edef75c9b4 schema:name Springer Nature - SN SciGraph project
193 rdf:type schema:Organization
194 Ndc0ce624c6da48e0a0a8a7dd74149203 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Kidney Function Tests
196 rdf:type schema:DefinedTerm
197 Ne7d8a2c6f350413c838a054f5888c518 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Adult
199 rdf:type schema:DefinedTerm
200 Ne8472b6b4343442b829786379fb7f807 schema:volumeNumber 45
201 rdf:type schema:PublicationVolume
202 Neb9783781abd4491b8a9d0e2ed0f6064 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Diuresis
204 rdf:type schema:DefinedTerm
205 Nf3408a8bb9054419b105390e596fbd56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Double-Blind Method
207 rdf:type schema:DefinedTerm
208 Nf37bf29e7fd6489db61fedd67564d4cf rdf:first sg:person.0767110303.39
209 rdf:rest N67857bfd19444507955b1e3958f97d2b
210 Nf5fc5c69becb406189e6deb65a003b18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Diuretics
212 rdf:type schema:DefinedTerm
213 Nf96b73bdba9942f6942d81126a42d171 rdf:first sg:person.010361144542.53
214 rdf:rest N5bb7f08e72da44b092b6d772baa41d44
215 Nfa34a605b2f346b087419c48c666dec6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
216 schema:name Female
217 rdf:type schema:DefinedTerm
218 Nfb9f66d2435f4368b8bce9c17efbda61 schema:name doi
219 schema:value 10.1007/s001010050271
220 rdf:type schema:PropertyValue
221 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
222 schema:name Medical and Health Sciences
223 rdf:type schema:DefinedTerm
224 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
225 schema:name Cardiorespiratory Medicine and Haematology
226 rdf:type schema:DefinedTerm
227 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
228 schema:name Clinical Sciences
229 rdf:type schema:DefinedTerm
230 sg:journal.1017033 schema:issn 0003-2417
231 1432-055X
232 schema:name Der Anaesthesist
233 schema:publisher Springer Nature
234 rdf:type schema:Periodical
235 sg:person.01003113502.88 schema:affiliation grid-institutes:grid.420011.6
236 schema:familyName Meyer
237 schema:givenName M.
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003113502.88
239 rdf:type schema:Person
240 sg:person.010361144542.53 schema:affiliation grid-institutes:None
241 schema:familyName Schlitt
242 schema:givenName H.-J.
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010361144542.53
244 rdf:type schema:Person
245 sg:person.01071356132.07 schema:affiliation grid-institutes:grid.424277.0
246 schema:familyName Überbacher
247 schema:givenName H. J.
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071356132.07
249 rdf:type schema:Person
250 sg:person.01243260701.18 schema:affiliation grid-institutes:grid.420011.6
251 schema:familyName Schulz-Knappe
252 schema:givenName P.
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01243260701.18
254 rdf:type schema:Person
255 sg:person.01316354712.56 schema:affiliation grid-institutes:grid.420011.6
256 schema:familyName Forssmann
257 schema:givenName W.-G.
258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01316354712.56
259 rdf:type schema:Person
260 sg:person.014700460114.77 schema:affiliation grid-institutes:None
261 schema:familyName Oldhafer
262 schema:givenName K.
263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014700460114.77
264 rdf:type schema:Person
265 sg:person.0664301646.04 schema:affiliation grid-institutes:None
266 schema:familyName Kuse
267 schema:givenName E.-R.
268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664301646.04
269 rdf:type schema:Person
270 sg:person.0767110303.39 schema:affiliation grid-institutes:None
271 schema:familyName Pichlmayr
272 schema:givenName R.
273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767110303.39
274 rdf:type schema:Person
275 grid-institutes:None schema:alternateName Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX
276 schema:name Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, XX
277 rdf:type schema:Organization
278 grid-institutes:grid.420011.6 schema:alternateName Niedersächsisches Institut für Peptid-Forschung (IPF), Hannover, XX
279 schema:name Niedersächsisches Institut für Peptid-Forschung (IPF), Hannover, XX
280 rdf:type schema:Organization
281 grid-institutes:grid.424277.0 schema:alternateName Boehringer Mannheim GmbH, Mannheim, XX
282 schema:name Boehringer Mannheim GmbH, Mannheim, XX
283 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...